Searched for: school:SOM
Department/Unit:Neurology
Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial
Duffley, Gordon; Szabo, Aniko; Lutz, Barbara J; Mahoney-Rafferty, Emily C; Hess, Christopher W; Ramirez-Zamora, Adolfo; Zeilman, Pamela; Foote, Kelly D; Chiu, Shannon; Pourfar, Michael H; Goas Cnp, Clarisse; Wood, Jennifer L; Haq, Ihtsham U; Siddiqui, Mustafa S; Afshari, Mitra; Heiry, Melissa; Choi, Jennifer; Volz, Monica; Ostrem, Jill L; San Luciano, Marta; Niemann, Nicki; Billnitzer, Andrew; Savitt, Daniel; Tarakad, Arjun; Jimenez-Shahed, Joohi; Aquino, Camila C; Okun, Michael S; Butson, Christopher R
INTRODUCTION:Deep brain stimulation (DBS) is an effective treatment for Parkinson's disease (PD), but its efficacy is tied to DBS programming, which is often time consuming and burdensome for patients, caregivers, and clinicians. Our aim is to test whether the Mobile Application for PD DBS (MAP DBS), a clinical decision support system, can improve programming. METHODS:We conducted an open-label, 1:1 randomized, controlled, multicenter clinical trial comparing six months of SOC standard of care (SOC) to six months of MAP DBS-aided programming. We enrolled patients between 30 and 80 years old who received DBS to treat idiopathic PD at six expert centers across the United States. The primary outcome was time spent DBS programming and secondary outcomes measured changes in motor symptoms, caregiver strain and medication requirements. RESULTS:We found a significant reduction in initial visit time (SOC: 43.8 ± 28.9 min n = 37, MAP DBS: 27.4 ± 13.0 min n = 35, p = 0.001). We did not find a significant difference in total programming time between the groups over the 6-month study duration. MAP DBS-aided patients experienced a significantly larger reduction in UPDRS III on-medication scores (-7.0 ± 7.9) compared to SOC (-2.7 ± 6.9, p = 0.01) at six months. CONCLUSION:MAP DBS was well tolerated and improves key aspects of DBS programming time and clinical efficacy.
PMID: 36966051
ISSN: 1873-5126
CID: 5463012
Teaching Video NeuroImage: Alternating Skew Deviation as a Manifestation of Anti-GAD65-Associated Cerebellitis
Bell, Carter; Drummond, Patrick S; Grossman, Scott N
PMCID:10065205
PMID: 36539301
ISSN: 1526-632x
CID: 5462092
Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis
Mohammadi, Soheil; Gouravani, Mahdi; Salehi, Mohammad Amin; Arevalo, J Fernando; Galetta, Steven L; Harandi, Hamid; Frohman, Elliot M; Frohman, Teresa C; Saidha, Shiv; Sattarnezhad, Neda; Paul, Friedemann
BACKGROUND AND OBJECTIVES/OBJECTIVE:Recent literature on multiple sclerosis (MS) demonstrates the growing implementation of optical coherence tomography-angiography (OCT-A) to discover potential qualitative and quantitative changes in the retina and optic nerve. In this review, we analyze OCT-A studies in patients with MS and examine its utility as a surrogate or precursor to changes in central nervous system tissue. METHODS:PubMed and EMBASE were systematically searched to identify articles that applied OCT-A to evaluate the retinal microvasculature measurements in patients with MS. Quantitative data synthesis was performed on all measurements which were evaluated in at least two unique studies with the same OCT-A devices, software, and study population compared to controls. A fixed-effects or random-effects model was applied for the meta-analysis based on the heterogeneity level. RESULTS:The study selection process yielded the inclusion of 18 studies with a total of 1552 evaluated eyes in 673 MS-associated optic neuritis (MSON) eyes, 741 MS without optic neuritis (MSNON eyes), and 138 eyes without specification for the presence of optic neuritis (ON) in addition to 1107 healthy control (HC) eyes. Results indicated that MS cases had significantly decreased whole image superficial capillary plexus (SCP) vessel density when compared to healthy control subjects in the analyses conducted on Optovue and Topcon studies (both P < 0.0001). Likewise, the whole image vessel densities of deep capillary plexus (DCP) and radial peripapillary capillary (RPC) were significantly lower in MS cases compared to HC (all P < 0.05). Regarding optic disc area quadrants, MSON eyes had significantly decreased mean RPC vessel density compared to MSNON eyes in all quadrants except for the inferior (all P < 0.05). Results of the analysis of studies that used prototype Axsun machine revealed that MSON and MSNON eyes both had significantly lower ONH flow index compared to HC (both P < 0.0001). CONCLUSIONS:This systematic review and meta-analysis of the studies reporting OCT-A measurements of people with MS confirmed the tendency of MS eyes to exhibit reduced vessel density in the macular and optic disc areas, mainly in SCP, DCP, and RPC vessel densities.
PMCID:10041805
PMID: 36973708
ISSN: 1742-2094
CID: 5463142
Guidelines and principles for the care of the cardiothoracic transplant patient in the intensive care unit
Nurok, Michael; Nunnally, Mark E; O'Connor, Michael; Pierson, Richard N; Baran, David A; Harper, Michael D; Malinoski, Darren; El Banayosy, Aly; Orija, Abiodun; Hall, Shelley; Edelman, Jeffrey D; Sundt, Thoralf M; Levine, Deborah; Kobashigawa, Jon; Nelson, David
Heart and lung transplant recipients require care provided by clinicians from multiple different specialties, each contributing unique expertise and perspective. The period the patient spends in the intensive care unit is one of the most critical times in the perioperative trajectory. Various organizational models of intensive care exist, including those led by intensivists, surgeons, transplant cardiologists, and pulmonologists. Coordinating timely efficient intensive care is an essential and logistically difficult goal. The present work product of the American Society of Transplantation's Thoracic and Critical Care Community of Practice, Critical Care Task Force outlines operational guidelines and principles that may be applied in different organizational models to optimize the delivery of intensive care for the cardiothoracic organ recipient.
PMID: 36964943
ISSN: 1399-0012
CID: 5462962
Three-dimensional multi-parameter brain mapping using MR fingerprinting
Menon, Rajiv G; Sharafi, Azadeh; Muccio, Marco; Smith, Tyler; Kister, Ilya; Ge, Yulin; Regatte, Ravinder R
The purpose of this study was to develop and test a 3D multi-parameter MR fingerprinting (MRF) method for brain imaging applications. The subject cohort included 5 healthy volunteers, repeatability tests done on 2 healthy volunteers and tested on two multiple sclerosis (MS) patients. A 3D-MRF imaging technique capable of quantifying T 1 , T 2 and T 1Ï was used. The imaging sequence was tested in standardized phantoms and 3D-MRF brain imaging with multiple shots (1, 2 and 4) in healthy human volunteers and MS patients. Quantitative parametric maps for T 1 , T 2 , T 1Ï , were generated. Mean gray matter (GM) and white matter (WM) ROIs were compared for each mapping technique, Bland-Altman plots and intra-class correlation coefficient (ICC) were used to assess repeatability and Student T-tests were used to compare results in MS patients. Standardized phantom studies demonstrated excellent agreement with reference T 1 /T 2/ T 1Ï mapping techniques. This study demonstrates that the 3D-MRF technique is able to simultaneously quantify T 1 , T 2 and T 1Ï for tissue property characterization in a clinically feasible scan time. This multi-parametric approach offers increased potential to detect and differentiate brain lesions and to better test imaging biomarker hypotheses for several neurological diseases, including MS.
PMCID:10055680
PMID: 36993561
ISSN: n/a
CID: 5534442
Learning critically drives parkinsonian motor deficits through imbalanced striatal pathway recruitment
Cheung, Timothy H C; Ding, Yunmin; Zhuang, Xiaoxi; Kang, Un Jung
Dopamine (DA) loss in Parkinson's disease (PD) causes debilitating motor deficits. However, dopamine is also widely linked to reward prediction and learning, and the contribution of dopamine-dependent learning to movements that are impaired in PD-which often do not lead to explicit rewards-is unclear. Here, we used two distinct motor tasks to dissociate dopamine's acute motoric effects vs. its long-lasting, learning-mediated effects. In dopamine-depleted mice, motor task performance gradually worsened with task exposure. Task experience was critical, as mice that remained in the home cage during the same period were relatively unimpaired when subsequently probed on the task. Repeated dopamine replacement treatments acutely rescued deficits and gradually induced long-term rescue that persisted despite treatment withdrawal. Surprisingly, both long-term rescue and parkinsonian performance decline were task specific, implicating dopamine-dependent learning. D1R activation potently induced acute rescue that gradually consolidated into long-term rescue. Conversely, reduced D2R activation potently induced parkinsonian decline. In dopamine-depleted mice, either D1R activation or D2R activation prevented parkinsonian decline, and both restored balanced activation of direct vs. indirect striatal pathways. These findings suggest that reinforcement and maintenance of movements-even movements not leading to explicit rewards-are fundamental functions of dopamine and provide potential mechanisms for the hitherto unexplained "long-duration response" by dopaminergic therapies in PD.
PMCID:10041136
PMID: 36920928
ISSN: 1091-6490
CID: 5448912
Quality improvement in the determination of death by neurologic criteria around the world
Lewis, Ariane; Kirschen, Matthew P; Badenes, Rafael
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2023. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2023 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .
PMCID:10029290
PMID: 36941711
ISSN: 1466-609x
CID: 5449132
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy [Letter]
Taha, Hash Brown; Hornung, Simon; Dutta, Suman; Fenwick, Leony; Lahgui, Otmane; Howe, Kathryn; Elabed, Nour; Del Rosario, Irish; Wong, Darice Y; Duarte Folle, Aline; Markovic, Daniela; Palma, Jose-Alberto; Kang, Un Jung; Alcalay, Roy N; Sklerov, Miriam; Kaufmann, Horacio; Fogel, Brent L; Bronstein, Jeff M; Ritz, Beate; Bitan, Gal
PMCID:10026428
PMID: 36935518
ISSN: 2047-9158
CID: 5466992
The BLV App Arcade: a new curated repository and evaluation rubric for mobile applications supporting blindness and low vision
Liu, Bennett M; Beheshti, Mahya; Naeimi, Tahareh; Zhu, Zhigang; Vedanthan, Rajesh; Seiple, William; Rizzo, John-Ross
PURPOSE/UNASSIGNED:Visual impairment-related disabilities have become increasingly pervasive. Current reports estimate a total of 36 million persons with blindness and 217 million persons with moderate to severe visual impairment worldwide. Assistive technologies (AT), including text-to-speech software, navigational/spatial guides, and object recognition tools have the capacity to improve the lives of people with blindness and low vision. However, access to such AT is constrained by high costs and implementation barriers. More recently, expansive growth in mobile computing has enabled many technologies to be translated into mobile applications. As a result, a marketplace of accessibility apps has become available, yet no framework exists to facilitate navigation of this voluminous space. MATERIALS AND METHODS/UNASSIGNED:We developed the BLV (Blind and Low Vision) App Arcade: a fun, engaging, and searchable curated repository of app AT broken down into 11 categories spanning a wide variety of themes from entertainment to navigation. Additionally, a standardized evaluation metric was formalized to assess each app in five key dimensions: reputability, privacy, data sharing, effectiveness, and ease of use/accessibility. In this paper, we describe the methodological approaches, considerations, and metrics used to find, store and score mobile applications. CONCLUSION/UNASSIGNED:The development of a comprehensive and standardized database of apps with a scoring rubric has the potential to increase access to reputable tools for the visually impaired community, especially for those in low- and middle-income demographics, who may have access to mobile devices but otherwise have limited access to more expensive technologies or services.
PMID: 36927193
ISSN: 1748-3115
CID: 5495902
Moving intra-individual variability (IIV) towards clinical utility: IIV measured using a commercial testing platform
Cho, Hyein; Pilloni, Giuseppina; Tahsin, Raisa; Best, Pamela; Krupp, Lauren; Oh, Cheongeun; Charvet, Leigh
OBJECTIVES:Intra-individual variability (IIV), measured across repeated response times (RT) during continuous psychomotor tasks, is an early marker of cognitive change in the context of neurodegeneration. To advance IIV towards broader application in clinical research, we evaluated IIV from a commercial cognitive testing platform and compared it to the calculation approaches used in experimental cognitive studies. METHODS:-transformed standard deviation or "LSD"). We calculated IIV from the raw RTs using coefficient of variation (CoV), regression-based, and ex-Gaussian methods. The IIV from each calculation was then compared by rank across participants. RESULTS:A total of n = 120 participants with MS aged 20-72 (Mean ± SD, 48.99 ± 12.09) completed the baseline cognitive measures. For each task, the interclass correlation coefficient was generated. Each ICC showed that LSD, CoV, ex-Gaussian, and regression methods clustered strongly (Average ICC for DET: 0.95 with 95% CI [0.93, 0.96]; Average ICC for IDN: 0.92 with 95% CI [0.88 to 0.93]; Average ICC for ONB: 0.93 with 95% CI [0.90 to 0.94]). Correlational analyses indicated the strongest correlation between LSD and CoV for all tasks (rs ≥ 0.94). CONCLUSION:The LSD was consistent with research-based methods for IIV calculations. These findings support the use of LSD for the future measurement of IIV for clinical studies.
PMID: 36812823
ISSN: 1878-5883
CID: 5430202